A high MGMT expression level is mechanistically linked to TMZ resistance in GBM, and elevated MGMT expression and/or the lack of MGMT promoter hypermethylation in patient tumor specimens is associated with worse outcomes in GBM patients treated with TMZ. This evidence concerns the gene MGMT and glioblastoma.